GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (NAS:ACOG) » Definitions » Research & Development

ACOG (Alpha Cognition) Research & Development : $4.10 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alpha Cognition's Research & Development for the three months ended in Sep. 2024 was $1.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $4.10 Mil.

Alpha Cognition Research & Development Historical Data

The historical data trend for Alpha Cognition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Research & Development Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
4.67 7.97 8.82 5.00

Alpha Cognition Quarterly Data
Jan20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.22 0.92 0.97 1.00

Alpha Cognition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition  (NAS:ACOG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alpha Cognition Research & Development Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Cognition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (NAS:ACOG) » Definitions » Research & Development
Comparable Companies
ANIX CNTX FBLG UNCY CTMX RVPH QNCX AADI ENTX BLUE VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
ACOG:Canada
Address
c/o 1200 – 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Website
https://www.alphacognition.com
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.